Anti-Human CD4 Recombinant Antibody(Zanolimumab)
-
产品编号
YR1135
-
别名
科研级 Zanolimumab ( 扎木单抗 ), Anti-CD4 Recombinant Antibody, Research Grade Zanolimumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Zanolimumab ( 扎木单抗 ), Anti-CD4 Recombinant Antibody, Research Grade Zanolimumab |
Catalog Number | YR1135 |
Molecular Name | Zanolimumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Zanolimumab (expected trade name HuMax-CD) is a human monoclonal antibody and an immunosuppressive drug. It was developed with the goal of treatment of rheumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma. Development of the drug was ultimately discontinued with termination of all trials. |
CAS Number | 652153-01-0 |
Application | Neut, ELISA, IF, IP, FuncS, FCM |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | CD4[Homo sapiens] |